Gene · 4050
Papers2,481
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,481
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP. | Discov Oncol | 2021 | 35201443 | PubTator, text mining | PubMed |
| Dissecting the Crosstalk Between Nrf2 and NF-κB Response Pathways in Drug-Induced Toxicity. | Front Cell Dev Biol | 2021 | 35186957 | PubTator, text mining | PubMed |
| Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer. | Front Immunol | 2021 | 35145509 | PubTator, text mining | PubMed |
| Tracking Immunoglobulin Repertoire and Transcriptomic Changes in Germinal Center B Cells by Single-Cell Analysis. | Front Immunol | 2021 | 35095922 | PubTator, text mining | PubMed |
| Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. | Front Immunol | 2021 | 35095855 | PubTator, text mining | PubMed |
| Communication Pattern Changes Along With Declined IGF1 of Immune Cells in COVID-19 Patients During Disease Progression. | Front Immunol | 2021 | 35095832 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease. | Front Neurol | 2021 | 35095746 | PubTator, text mining | PubMed |
| Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function. | Front Immunol | 2021 | 35082797 | PubTator, text mining | PubMed |
| Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification. | Front Immunol | 2021 | 35069566 | PubTator, text mining | PubMed |
| GOLT1B Activation in Hepatitis C Virus-Infected Hepatocytes Links ER Trafficking and Viral Replication. | Pathogens | 2021 | 35055994 | PubTator, text mining | PubMed |
| Phytochemicals: Potential Therapeutic Modulators of Radiation Induced Signaling Pathways. | Antioxidants (Basel) | 2021 | 35052553 | PubTator, text mining | PubMed |
| Identification of key genes and microRNAs for multiple sclerosis using bioinformatics analysis. | Medicine (Baltimore) | 2021 | 35049167 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals the Immune Characteristics of Myeloid Cells and Memory T Cells in Recovered COVID-19 Patients With Different Severities. | Front Immunol | 2021 | 35046942 | PubTator, text mining | PubMed |
| Recent Advances in the Genetic of MALT Lymphomas. | Cancers (Basel) | 2021 | 35008340 | PubTator, text mining | PubMed |
| Single-cell RNA Seq reveals cellular landscape-specific characteristics and potential etiologies for adolescent idiopathic scoliosis. | JOR Spine | 2021 | 35005449 | PubTator, text mining | PubMed |
| LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets. | Front Immunol | 2021 | 35003113 | PubTator, text mining | PubMed |
| Neuroinflammatory gene expression analysis reveals potential novel mediators and treatment targets in interstitial cystitis with Hunner lesions. | Transl Androl Urol | 2021 | 34984176 | PubTator, text mining | PubMed |
| B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management. | Int J Mol Sci | 2021 | 34948358 | PubTator, text mining | PubMed |
| Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges. | Cells | 2021 | 34943817 | PubTator, text mining | PubMed |
| Recent Advancements and Future Perspectives of Microalgae-Derived Pharmaceuticals. | Mar Drugs | 2021 | 34940702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4050/papers?page=35